Effects of ketanserin and 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H,3H)- quinazolinedione monohydrochloride (SGB-1534), anti-hypertensive agents, on 3H-serotonin and 3H-ketanserin bindings to serotonergic (5HT1 and 5HT2) receptors in dog brain and aorta.
Nagatomo
T
T
Hokibara
R
R
Tanaka
Y
Y
Nakamura
T
T
Aono
J
J
Tsuchihashi
H
H
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D004285:Dogs; D005260:Female; D066298:In Vitro Techniques; D007650:Ketanserin / Q000378:metabolism / Q000494:pharmacology*; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism*; D011799:Quinazolines / Q000494:pharmacology*; D011985:Receptors, Serotonin / Q000187:drug effects / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism*
D000319:Adrenergic beta-Antagonists; D011799:Quinazolines; D011985:Receptors, Serotonin; D012701:Serotonin; C042712:SGB 1534; D007650:Ketanserin